Skip to main content
OpenTrials
Completed

NCT Number: NCT02385890

PERFECT Project - Part 1 - Study 3

The objectives are to test the acute effects of different bagels containing pulse ingredients on: 1) post-prandial blood glucose, insulin and appetite for two hours, and 2) food intake two hours following consumption of pulse products.

The investigators hypothesize that bagels containing pulse ingredients will lead to lower blood glucose, insulin, appetite and food intake responses compared to non-pulse bagels.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Prevention Obesity Prevention

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba

Winnipeg, Manitoba, R3T 6C5, Canada

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Normoglycemic (<5.6 mmol/L) and normotensive (systolic blood pressure <140 mm Hg and diastolic blood pressure below < 90 mm Hg)
  • BMI of 18.5-29.9 kg/m2

Exclusion criteria

  • Restrained eaters
  • Regularly skip breakfast
  • Smokers
  • Those who are active (organized activities or athletic training at a high intensity; ≥ 150 min per week of moderate to vigorous physical activity)
  • Those on medications that may influence study outcomes or have experienced any gastrointestinal related health conditions/surgeries over the past year.
  • Those unable to walk for an hour continuously

Treatment and study plan

Control

Other

Non pulse ingredient bagel

Pea flour

Other

Pulse ingredient bagel

Pea fibre

Other

Pulse ingredient bagel

Pea protein

Other

Pulse ingredient bagel

Pea flour + pea protein

Other

Pulse ingredient bagel

Pea fibre + pea protein

Other

Pulse ingredient bagel

Primary outcomes

  1. Plasma Glucose and Insulin Concentrations

    Time frame: 0-200

    Measured in blood using intravenous catheter at 12 time points used to calculate area under curve (AUC). Glucose will be determined by automated methods using Abbot Spectrum CCX Analyzer, and Insulin will be measured by commercially available RIA kits

  2. Food Intake

    Time frame: at 120 min

    Ad-libitum meal. Food consumed measured by weight

  3. Subjective Appetite

    Time frame: 0-200 min

    Motivation-to-eat VAS questionnaire used to calculate area under curve (AUC)

Secondary outcomes

  1. Palatability of meal

    Time frame: at 140 mins

    Measured by VAS questionnaire

  2. Palatability of treatments

    Time frame: at 5 mins

    Measured by VAS questionnaire

  3. Physical comfort

    Time frame: 0 - 200 min

    Measured by VAS questionnaire at 12 time points used to calculate area under curve (AUC)

  4. Energy/fatigue measured by VAS questionnaire

    Time frame: 0 - 200 mins

    Measured by VAS questionnaire at 12 time points, used to calculate area under curve (AUC)

Sponsors and collaborators

Lead sponsor

University of Manitoba

Other

Collaborators

  • Alberta Pulse Growers
  • Saskatchewan Pulse Growers

Registry information

Official study title

Pulse EnRiched Food and Exercise Clinical Trials (PERFECT Project): Part 1 - Acute Effects of Pulse Ingredients in Snack Products on Appetite, Blood Glucose, and Food Intake in Adults - Study 3

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Mar 11, 2015
Registry last updated
Jan 23, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.